BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29878370)

  • 1. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
    Hester CA; Augustine MM; Choti MA; Mansour JC; Minter RM; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Surg Oncol; 2018 Jul; 118(1):21-30. PubMed ID: 29878370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
    Braun R; Klinkhammer-Schalke M; Zeissig SR; Kleihus van Tol K; Bolm L; Honselmann KC; Petrova E; Lapshyn H; Deichmann S; Abdalla TSA; Heckelmann B; Bronsert P; Zemskov S; Hummel R; Keck T; Wellner UF
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.
    Boyd CA; Benarroch-Gampel J; Sheffield KM; Cooksley CD; Riall TS
    J Surg Res; 2012 May; 174(1):12-9. PubMed ID: 21816433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study.
    Imaoka H; Shimizu Y; Mizuno N; Hara K; Hijioka S; Tajika M; Kondo S; Tanaka T; Ogura T; Obayashi T; Hasegawa T; Niwa Y; Yamao K
    Pancreas; 2014 Mar; 43(2):287-90. PubMed ID: 24518509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.
    Komatsu H; Egawa S; Motoi F; Morikawa T; Sakata N; Naitoh T; Katayose Y; Ishida K; Unno M
    Surg Today; 2015 Mar; 45(3):297-304. PubMed ID: 24973941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report.
    Hoshimoto S; Hoshi N; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(5):788-794. PubMed ID: 28784574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.
    Murimwa G; Hester C; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Gastrointest Surg; 2021 Jul; 25(7):1815-1827. PubMed ID: 32705618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets.
    Silvestris N; Brunetti O; Pinto R; Petriella D; Argentiero A; Fucci L; Tommasi S; Danza K; De Summa S
    Expert Opin Ther Targets; 2018 May; 22(5):453-461. PubMed ID: 29561217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).
    Paniccia A; Hosokawa PW; Schulick RD; Henderson W; Kaplan J; Gajdos C
    Surgery; 2016 Aug; 160(2):281-92. PubMed ID: 27085687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?
    Ostapoff KT; Gabriel E; Attwood K; Kuvshinoff BW; Nurkin SJ; Hochwald SN
    HPB (Oxford); 2017 Jul; 19(7):587-594. PubMed ID: 28433254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas.
    Lenkiewicz E; Malasi S; Hogenson TL; Flores LF; Barham W; Phillips WJ; Roesler AS; Chambers KR; Rajbhandari N; Hayashi A; Antal CE; Downes M; Grandgenett PM; Hollingsworth MA; Cridebring D; Xiong Y; Lee JH; Ye Z; Yan H; Hernandez MC; Leiting JL; Evans RM; Ordog T; Truty MJ; Borad MJ; Reya T; Von Hoff DD; Fernandez-Zapico ME; Barrett MT
    Cancer Res; 2020 Oct; 80(20):4324-4334. PubMed ID: 32928922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States.
    Ordonez JE; Hester CA; Zhu H; Augustine M; Porembka MR; Wang SC; Yopp AC; Mansour JC; Zeh HJ; Polanco PM
    Ann Surg Oncol; 2020 Jun; 27(6):1997-2006. PubMed ID: 31894482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome of adenosquamous carcinoma of the pancreas.
    Okabayashi T; Hanazaki K
    World J Gastroenterol; 2008 Nov; 14(44):6765-70. PubMed ID: 19058301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.